I. S. Lebedev

I. S. Lebedev

Auto-generated profile, based on publicly available information

I. S. Lebedev

Pirogov Russian National Research Medical University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2023 in Journal of Venous Disorders
Verified
Journal Article
Closed access
AKAlvina Khachatryan
Alvina Khachatryan
EAE.S. An
E.S. An
ESE.I. Seliverstov
E.I. Seliverstov
ILI.S. Lebedev
I.S. Lebedev
Treatment of deep vein thrombosis (DVT) has changed and evolved with discovery of new drugs and modern invasive methods of diagnosis and treatment. To date, anticoagulation is the generally accepted approach for DVT of the lower extremities. At the same time, endovascular treatment of these patients is interesting. These methods include catheter thrombolysis, endovascular mechanical thromboextraction and their combination. Large-scale randomized clinical trials have shown that such interventions are not advisable in all patients with DVT. Effectiveness and feasibility of these interventions are determined by such criteria as age, DVT extent, severity of symptoms and duration of disease. The most perspective group for endovascular treatment of DVT are patients with iliofemoral thrombosis, as well as patients younger than 65 years and those with severe symptoms (Villalta score > 15). Optimal timing for such interventions is unclear. Early interventions may be more effective considering pathophysiological changes in the thrombus over time. When planning catheter thrombolysis, we should analyze risk-to-benefit ratio, absolute and relative contraindications. Currently, there are devices for endovascular thromboextraction from various veins. Each tool has different properties depending on clinical objective.

1 January 2022 in Journal of Venous Disorders
Verified
Journal Article
Closed access
ILI.S. Lebedev
I.S. Lebedev
MGM.YU. Gilyarov
M.YU. Gilyarov
OEOksana Efremova
Oksana Efremova
IZIgor A. Zolotukhin
Igor A. Zolotukhin
AKA.I. Kirienko
A.I. Kirienko
Массивная тромбоэмболия легочных артерий (ТЭЛА) при несвоевременной диагностике и лечении может привести к смерти пациента в острой стадии заболевания или развитию тяжелой постэмболической легочной гипертензии в отдаленном периоде. Современные клинические рекомендации, составленные разными врачебными сообществами, помогают выбрать надлежащую лечебную тактику. Тем не менее шаблонное выполнение рекомендаций может приводить к негативным результатам. ЦЕЛЬ РАБОТЫ На клиническом примере показать необходимость многостороннего похода к решению тактических вопросов, основанного на сочетании прогностических шкал, клинических рекомендаций и врачебной интуиции, к ведению пациентов с острым венозным тромбозом, осложненным массивной ТЭЛА. МАТЕРИАЛ И МЕТОДЫ Представлено наблюдение пациента с переломом костей голени, осложнившимся развитием тромбоза глубоких вен и массивной ТЭЛА. Несмотря на соблюдение современных клинических рекомендаций, наступил летальный исход в результате рецидива ТЭЛА. Проведен анализ клинической ситуации, сделаны предположения о причинах такого исхода и нереализованных альтернативных вариантах врачебных действий. ЗАКЛЮЧЕНИЕ Клинические рекомендации не являются универсальным механизмом выбора лечебной тактики. Необходимо дополнять предлагаемые ими алгоритмы индивидуальной оценкой ситуации и принимать решение, основываясь на комплексном клиническом подходе.

23 April 2023 in Journal of Venous Disorders
Verified
Journal Article
Closed access
SGSergey Gavrilov
Sergey Gavrilov
ILI.S. Lebedev
I.S. Lebedev
AVA.V. Vasiliev
A.V. Vasiliev
NMN.YU. Mishakina
N.YU. Mishakina
Considering literature and clinical data, the authors present the arguments in favor of stenting in patients with chronic venous obstructions. Modern literature devoted to stenting for chronic thrombotic and non-thrombotic obstruction of iliac veins was analyzed. Currently, classical and special venous stents are used for iliac vein stenting. The latter have greater flexibility and radial strength. They are not accompanied by such complications as stent-related occlusion of contralateral common iliac vein and cone-shaped narrowing of both ends of the stent. Literature data indicate high efficiency of stenting for recanalization of iliac veins in patients with thrombotic and non-thrombotic iliac vein obstructions. Stent patency varies from 79 to 100% within 1—3 years. Relief of edematous and pain syndrome, as well as healing of trophic ulcer occurs in 70—100% of patients. Comparison of the cost of venous stenting and standard therapy indicates that endovascular intervention is accompanied by significantly lower treatment cost and less period of temporary disability. Clinical examples demonstrate the possibilities of iliac vein stenting in patients with post-thrombotic disease, combination of May-Thurner syndrome and pelvic venous congestion. Venous stenting is effective and safe for recanalization of great veins, correction of chronic venous insufficiency and pelvic venous congestion syndrome. This approach reduces treatment cost in patients with chronic venous obstructions.

18 March 2024 in Journal of Venous Disorders
Verified
Journal Article
Closed access
DRDenis Rylnikov
Denis Rylnikov
ILI.S. Lebedev
I.S. Lebedev
SYS.M. Yumin
S.M. Yumin
ESE.I. Seliverstov
E.I. Seliverstov
The review is devoted to modern literature data on floating venous thrombosis. Historical data regarding surgical venous disconnection and recanalization are presented. The authors reviewed modern studies devoted to embolism-threatening thrombosis and appropriate international recommendations. Deep vein thrombosis (DVT) of the lower extremities and pelvis is characterized by clotting in appropriate veins. Pulmonary embolism (PE) is the main and life-threatening complication of DVT. Floating thrombosis is believed to be very dangerous for many years and absolutely requires surgical prevention of PE. Nevertheless, appropriate data are contradictory. Most professional communities recognize impossible anticoagulation as the only indication for cava filter implantation. National guidelines (2023) do not recognize proximal floating thrombus as the only indication for cava filter implantation. Unclear role of floating clots as a risk factor for PE forces specialists to continue cava filter implantation in these cases to this day. Importantly, percutaneous cava filter implantation is really not always possible. This fact requires more invasive partial and complete disconnection with higher incidence of complications, such as ligation of superficial femoral vein, plication of inferior vena cava and open thrombectomy. These features inspired us to analyze venous thrombosis as a risk factor of pulmonary embolism.

18 March 2024 in Journal of Venous Disorders
Verified
Journal Article
Closed access
AKA.S. Kuperin
A.S. Kuperin
LGL.L. Gusev
L.L. Gusev
OAO.A. Alukhanyan
O.A. Alukhanyan
ESE.I. Seliverstov
E.I. Seliverstov
ILI.S. Lebedev
I.S. Lebedev
Venous thromboembolism (VTE) is an important problem for public healthcare systems. Deep vein thrombosis (DVT) of the lower extremities leads to post-thrombotic syndrome (PTS) in 20—50% of cases. Endovascular management of DVT in patients with iliofemoral thrombosis reduces the risk of severe forms of PTS. There are various endovascular procedures including catheter-directed thrombolysis (CDT), mechanical thrombectomy (MT), and their combination. Such interventions require a multidisciplinary approach and involvement of a surgeon. Despite the long history of investigations in this field, many questions are still unresolved, i.e. implantation of cava-filter, optimal venous access and device, anticoagulant agent in acute period. Venous stents in addition to CDT or MT can improve the outcomes. Primary patency rate among different types of venous stents is identical. The choice of stent type is still up to a surgeon and depends on economic affordability as a main limiting factor. Currently, there are no standardized protocols for such endovascular procedures. There are numerous characteristics complicating this process such as disease duration, anatomical features and technical capabilities of hospitals. It is also important to consider the economic aspect of such interventions, especially when combining multiple techniques (MT and stenting). Only a small percentage of patients are potentially eligible for endovascular treatment of DVT. Therefore, these interventions are advisable in hospitals with large number of such patients.

11 August 2024 in Koloproktologia
Verified
Journal Article
Open access
PDF file
ASA. V. Sazhin
A. V. Sazhin
IEI. V. Ermakov
I. V. Ermakov
GIG. B. Ivakhov
G. B. Ivakhov
ILI. S. Lebedev
I. S. Lebedev
KDK. D. Dalgatov
K. D. Dalgatov
NTN. A. Timoshenko
N. A. Timoshenko
   AIM: to present the primary experience of performing intracorporeal linear colorectal anastomosis using the “overlap” technique in laparoscopic anterior rectal resection.   MATERIALS AND METHODS: the study presents the outcomes of intracorporeal linear “overlap” anastomosis in patients who underwent laparoscopic anterior rectal resection between October 2023 and February 2024. The results were evaluated based on various parameters including operation time, the postoperative morbidity rate (by Clavien-Dindo scale), conversion rates, hospital stay, quality of life by SF-36 questionnaire 30 days after surgery.   RESULTS: the linear “overlap” anastomosis was done in 10 patients (5 females), aged 62.0 ± 9.03 years and BMI of 27.5 ± 7.2 kg/m2. No intraoperative complications occurred. One patient developed a seroma at the incision site (Clavien–Dindo I). The first bowel movement was at 1 (0–3) days after surgery. The post-op hospital stay was 5.7 ± 1.9 days.   CONCLUSION: primary results demonstrate the simplicity and safety of intracorporeal linear “overlap” anastomosis technique. The further advanced study is justified.